A transcranial magnetic stimulation study evaluating methylprednisolone treatment in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 105, Issue 3, 2002, Pages 152-157

  Fierro, B ^a   Salemi, G ^a   Brighina, F ^a   Buffa, D ^a   Conte, S ^a   La Bua, V ^a   Piazza, A ^a   Savettieri, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

High dose methylprednisolone; Multiple sclerosis; Randomized trial; Transcranial magnetic stimulation

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; MOTOR NERVE CONDUCTION; MULTIPLE SCLEROSIS; NEUROPHYSIOLOGY; RECURRENT DISEASE; SCORING SYSTEM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; RECURRENCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 0036196862     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.1o369.x     Document Type: Article

References (27)

1. Megadose corticosteroids in multiple sclerosis
2. Double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects
3. Randomized trial comparing two different high doses of methylprednisolone in MS. A clinical and MRI study
4. The sensitivity of transcranial cortical magnetic stimulation in detecting pyramidal tract lesions in clinically definite multiple sclerosis
5. The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis
6. Improvement in motor evoked potentials and clinical course post-steroid therapy in multiple sclerosis
7. The role of magnetic stimulation as a quantifier of motor disability in patients with multiple sclerosis
8. Effect of high dose corticosteroid therapy on central motor conduction time (CMCT) in attacks of multiple sclerosis
9. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
10. Rating neurological impairment in multiple sclerosis: An expanded disability scale (EDSS)
11. Non-invasive magnetic stimulation of human motor cortex
12. Role of intracortical mechanisms in the late part of the silent period to transcranial stimulation of the human motor cortex
13. Central motor conduction in multiple sclerosis: Evaluation of abnormalities revealed by transcutaneous magnetic stimulation of the brain
14. Lower extremity motor evoked potentials in multiple sclerosis
15. Magnetic brain stimulation: Central motor conduction in multiple sclerosis
16. Effects of high to mega dose synthetic corticosteroids on multiple sclerosis patients with special reference to cerebrospinal fluid antibodies to myelin basic protein
17. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis
18. Interrater variability with Expanded Disability Status scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trail
19. A neurologic rating scale (NRS) for use in multiple sclerosis
20. Latency and duration of the muscle silent period following transcranial magnetic stimulation in multiple sclerosis, cerebral ischemia, and other upper motoneuron lesions
21. Standardization of facilitation of compound muscle action potentials evoked by magnetic stimulation of the cortex
22. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease
23. Inhibitory actions of motor cortex following unilateral brain lesions as studied by magnetic brain stimulation
24. The silent period after transcranial magnetic stimulation is of exclusive cortical origin: Evidence from isolated cortical ischemic lesions in man
25. Cortical excitability in amyotrophic lateral sclerosis: A clue to pathogenesis
26. The role of transcranial magnetic stimulation and motor evoked potentials in the investigation of central motor pathways in multiple sclerosis